Here, we report a study of JAK2 (V617F) mutation in 75 normal subjects referred to the Outpatient Section of the Department of Haematology of Pavia. These healthy individuals (aged from 18 to 79 years) displayed a normal blood cell count without spleen enlargement. Applying AS-PCR as previously described (Passamonti et al, 2006), we did not find the mutation in any case.

JAK2 (V617F) mutation in healthy individuals

PASSAMONTI, FRANCESCO;RUMI, ELISA;LAZZARINO, MARIO;CAZZOLA, MARIO
2007-01-01

Abstract

Here, we report a study of JAK2 (V617F) mutation in 75 normal subjects referred to the Outpatient Section of the Department of Haematology of Pavia. These healthy individuals (aged from 18 to 79 years) displayed a normal blood cell count without spleen enlargement. Applying AS-PCR as previously described (Passamonti et al, 2006), we did not find the mutation in any case.
2007
The Hematology category covers resources concerned with blood, blood-forming tissues, bone marrow, plasma, and transfusions. Coverage also includes resources on specialties such as hemophilia, leukemia, and lymphoma.
Sì, ma tipo non specificato
Inglese
Internazionale
STAMPA
136
4
678
679
2
Title: British journal of haematology ISSN: 0007-1048 (Print) 1365-2141 (Electronic)
JAK2; Myeloproliferative neoplasm
5
info:eu-repo/semantics/article
262
Passamonti, Francesco; Rumi, Elisa; Pietra, D; Lazzarino, Mario; Cazzola, Mario
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/143311
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 28
social impact